检索结果 - Robert A. Wolff
- Showing 1 - 20 results of 119
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer 由 Paulo M. Hoff, Scott Kopetz, Melanie B. Thomas, Adrian Langleben, David Rinaldi, Lowell Anthony, Robert A. Wolff, Yvonne Lassere, James L. Abbruzzese
出版 2008Artigo -
14
-
15
Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Thera... 由 Christopher H. Crane, Kathryn Winter, William F. Regine, Howard Safran, Tyvin A. Rich, Walter J. Curran, Robert A. Wolff, Christopher G. Willett
出版 2009Artigo -
16
-
17
Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial 由 Henry Q. Xiong, Arthur Rosenberg, Albert F. LoBuglio, William Schmidt, Robert A. Wolff, John C. Deutsch, Michael N. Needle, James L. Abbruzzese
出版 2004Artigo -
18
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma 由 Reham Abdel‐Wahab, Gauri R. Varadhachary, Priya Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle
出版 2018Artigo -
19
-
20
相关主题
Medicine
Internal medicine
Cancer
Oncology
Pancreatic cancer
Adenocarcinoma
Gastroenterology
Biology
Colorectal cancer
Chemotherapy
Surgery
Breast cancer
Cancer research
Gene
Pancreas
Genetics
Gemcitabine
Neoadjuvant therapy
Confidence interval
Radiation therapy
KRAS
Paleontology
Clinical trial
Environmental health
Population
Radiology
Stage (stratigraphy)
Capecitabine
Multivariate analysis
Pancreatic ductal adenocarcinoma